Clinical Trial: Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: An Open-Label, Dose-Escalating Efficacy and Safety Study of Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy

Brief Summary: The purpose of this study is to determine if implitapide is effective in lowering triglyceride (TG) levels in patients with Fredrickson Type I or V hypertriglyceridemia where the maximum tolerable medication and diet were not sufficient.

Detailed Summary:
Sponsor: Medical Research Laboratories International

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Medical Research Laboratories International

Dates:
Date Received: March 23, 2004
Date Started: October 2004
Date Completion: April 2005
Last Updated: June 23, 2005
Last Verified: April 2005